MRD for predicting outcome in MCL. AlloSCT, allogeneic stem celltransplant; autoSCT, autologous stem cell transplant; BCL2i, BCL2 inhibitor; BTKi, Bruton tyrosine kinase inhibitor; CART, chimeric antigen receptor T cell; PI, proteasome inhibitor.